**Flu activity remains at typical off-season lows in mid-August, with CDC FluSurv-NET data showing weekly influenza-associated hospitalization rates declining to 0.1–0.2 per 100,000 population by late May and minimal levels thereafter.** Lab positivity rates have fallen below 2%, consistent with historical patterns outside the October–May season when influenza circulation is suppressed by warmer temperatures, reduced indoor crowding, and lower viral survival. Week 32 rates near the 0.1 threshold reflect sparse confirmed cases amid baseline respiratory illness surveillance, creating tight market-implied odds as traders weigh minor year-to-year variability, potential reporting lags in FluSurv-NET data, and the possibility of isolated detections pushing the precise rate slightly above or below the cutoff. Upcoming weekly updates from CDC surveillance will provide the final resolution data.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоКоэффициент госпитализации в связи с гриппом на 32 неделе 2026 года?
Коэффициент госпитализации в связи с гриппом на 32 неделе 2026 года?
<0,1 45%
0,1 45%
>0,1 37%
НОВОЕ
НОВОЕ
21 авг. 2026 г.
<0,1
45%
0,1
45%
>0,1
37%
<0,1 45%
0,1 45%
>0,1 37%
НОВОЕ
НОВОЕ
21 авг. 2026 г.
<0,1
$0 Объем
45%
0,1
$0 Объем
45%
>0,1
$117 Объем
37%
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Flu activity remains at typical off-season lows in mid-August, with CDC FluSurv-NET data showing weekly influenza-associated hospitalization rates declining to 0.1–0.2 per 100,000 population by late May and minimal levels thereafter.**
Lab positivity rates have fallen below 2%, consistent with historical patterns outside the October–May season when influenza circulation is suppressed by warmer temperatures, reduced indoor crowding, and lower viral survival. Week 32 rates near the 0.1 threshold reflect sparse confirmed cases amid baseline respiratory illness surveillance, creating tight market-implied odds as traders weigh minor year-to-year variability, potential reporting lags in FluSurv-NET data, and the possibility of isolated detections pushing the precise rate slightly above or below the cutoff. Upcoming weekly updates from CDC surveillance will provide the final resolution data.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Открытие рынка: Aug 14, 2026, 2:18 PM ET
Объем
$117Дата окончания
21 авг. 2026 г.Открытие рынка
Aug 14, 2026, 2:18 PM ETResolver
0x69c47De9D...This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Flu activity remains at typical off-season lows in mid-August, with CDC FluSurv-NET data showing weekly influenza-associated hospitalization rates declining to 0.1–0.2 per 100,000 population by late May and minimal levels thereafter.**
Lab positivity rates have fallen below 2%, consistent with historical patterns outside the October–May season when influenza circulation is suppressed by warmer temperatures, reduced indoor crowding, and lower viral survival. Week 32 rates near the 0.1 threshold reflect sparse confirmed cases amid baseline respiratory illness surveillance, creating tight market-implied odds as traders weigh minor year-to-year variability, potential reporting lags in FluSurv-NET data, and the possibility of isolated detections pushing the precise rate slightly above or below the cutoff. Upcoming weekly updates from CDC surveillance will provide the final resolution data.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Объем
$117Дата окончания
21 авг. 2026 г.Открытие рынка
Aug 14, 2026, 2:18 PM ETResolver
0x69c47De9D...**Flu activity remains at typical off-season lows in mid-August, with CDC FluSurv-NET data showing weekly influenza-associated hospitalization rates declining to 0.1–0.2 per 100,000 population by late May and minimal levels thereafter.** Lab positivity rates have fallen below 2%, consistent with historical patterns outside the October–May season when influenza circulation is suppressed by warmer temperatures, reduced indoor crowding, and lower viral survival. Week 32 rates near the 0.1 threshold reflect sparse confirmed cases amid baseline respiratory illness surveillance, creating tight market-implied odds as traders weigh minor year-to-year variability, potential reporting lags in FluSurv-NET data, and the possibility of isolated detections pushing the precise rate slightly above or below the cutoff. Upcoming weekly updates from CDC surveillance will provide the final resolution data.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы